90 related articles for article (PubMed ID: 1826545)
21. Ocular fluorophotometry in streptozotocin diabetes mellitus in the rat: effect of pancreatic islet isografts.
Krupin T; Waltman SR; Scharp DW; Oestrich C; Feldman SD; Becker B; Ballinger WF; Lacy PE
Invest Ophthalmol Vis Sci; 1979 Nov; 18(11):1185-90. PubMed ID: 116969
[TBL] [Abstract][Full Text] [Related]
22. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
23. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment.
Usta MF; Bivalacqua TJ; Koksal IT; Toptas B; Surmen S; Hellstrom WJ
BJU Int; 2004 Aug; 94(3):429-32. PubMed ID: 15291881
[TBL] [Abstract][Full Text] [Related]
24. Onset of changes in glucose transport across ocular barriers in streptozotocin-induced diabetes.
DiMattio J; Zadunaisky JA; Altszuler N
Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):820-6. PubMed ID: 6735646
[TBL] [Abstract][Full Text] [Related]
25. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
26. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
[TBL] [Abstract][Full Text] [Related]
27. Vitreous fluorophotometry in juvenile diabetes.
Kernell A; Larsson Y; Ludvigsson J; Tenland T
Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
[TBL] [Abstract][Full Text] [Related]
28. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
29. Vitreous fluorophotometry in rats with streptozocin-induced diabetes.
Vine AK; Kisly AM; Betz AL; Howatt WF
Arch Ophthalmol; 1984 Jul; 102(7):1083-5. PubMed ID: 6743087
[TBL] [Abstract][Full Text] [Related]
30. A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats.
Iwase M
Fukuoka Igaku Zasshi; 1991 Jul; 82(7):415-27. PubMed ID: 1833297
[TBL] [Abstract][Full Text] [Related]
31. Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes.
Enea NA; Hollis TM; Kern JA; Gardner TW
Arch Ophthalmol; 1989 Feb; 107(2):270-4. PubMed ID: 2521787
[TBL] [Abstract][Full Text] [Related]
32. Kinetic vitreous fluorophotometry in experimental diabetes.
Jones CW; Cunha-Vaz J; Zweig KO; Stein M
Arch Ophthalmol; 1979 Oct; 97(10):1941-3. PubMed ID: 485921
[TBL] [Abstract][Full Text] [Related]
33. Effect of insulin treatment on the blood-retinal barrier in rats with streptozocin-induced diabetes.
Kernell A; Arnqvist H
Arch Ophthalmol; 1983 Jun; 101(6):968-70. PubMed ID: 6344848
[TBL] [Abstract][Full Text] [Related]
34. Effect of diabetes on transscleral delivery of celecoxib.
Cheruvu NP; Amrite AC; Kompella UB
Pharm Res; 2009 Feb; 26(2):404-14. PubMed ID: 18987961
[TBL] [Abstract][Full Text] [Related]
35. Fluorophotometry. III. Streptozocin-treated rats and rats with pancreatectomy.
Klein R; Wallow II; Ernest JT
Arch Ophthalmol; 1980 Dec; 98(12):2235-7. PubMed ID: 6449921
[TBL] [Abstract][Full Text] [Related]
36. Development of electroretinographic alterations in streptozotocin-induced diabetes in rats.
Sakai H; Tani Y; Shirasawa E; Shirao Y; Kawasaki K
Ophthalmic Res; 1995; 27(1):57-63. PubMed ID: 7596561
[TBL] [Abstract][Full Text] [Related]
37. Vitreous fluorescein accumulation determined by in vivo fluorophotometry and by vitreous extraction in normal and diabetic rats.
Kaufmann F; Lacoste C
Diabetologia; 1986 Mar; 29(3):175-80. PubMed ID: 3516774
[TBL] [Abstract][Full Text] [Related]
38. Fluorophotometry. II. Streptozocin-treated guinea pigs.
Klein R; Engerman RL; Ernest JT
Arch Ophthalmol; 1980 Dec; 98(12):2233-4. PubMed ID: 7447783
[TBL] [Abstract][Full Text] [Related]
39. Vitreous fluorophotometry in three models of experimental diabetes mellitus.
Smith SS; Ashburn FS; Pilkerton AR; Recant L
Retina; 1982; 2(2):121-5. PubMed ID: 6217532
[TBL] [Abstract][Full Text] [Related]
40. Vitreous fluorophotometry in the alloxan- and streptozocin-treated rat.
Jones CW; Cunha-Vaz JG; Rusin MM
Arch Ophthalmol; 1982 Jul; 100(7):1141-5. PubMed ID: 6212041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
